These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 5549938)

  • 1. Urinary monoamine metabolites in children with minimal brain dysfunction.
    Wender PH; Epstein RS; Kopin IJ; Gordon EK
    Am J Psychiatry; 1971 Apr; 127(10):1411-5. PubMed ID: 5549938
    [No Abstract]   [Full Text] [Related]  

  • 2. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cannabis sativa administered by smoking on biogenic amine excretion in man.
    Messiha FS; Soskin RA
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):325-8. PubMed ID: 4734006
    [No Abstract]   [Full Text] [Related]  

  • 5. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
    Zametkin AJ; Linnoila M; Karoum F; Sallee R
    Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The excretion of vanilmandelic acid, vanillic acid, homovanillic acid and 5-hydroxyindoleacetic acid by urine in smokers and non-smokers].
    Schmid E; Tautz NA; Bauersachs E; Krautheim J
    Arzneimittelforschung; 1968 Jul; 18(7):819-21. PubMed ID: 5755826
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of reserpine on catecholamine metabolism and behavior in retarded children.
    Anton AH
    Clin Pharmacol Ther; 1966; 7(6):727-39. PubMed ID: 5918009
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipramine-mediated effects on levodopa metabolism in man.
    Messiha FS; Morgan JP
    Biochem Pharmacol; 1974 May; 23(10):1503-7. PubMed ID: 4847533
    [No Abstract]   [Full Text] [Related]  

  • 10. A three solvent partition chromatographic technique for the estimation of acid metabolites of catecholamines. Urinary DOMA, DOPAC and HVA.
    Vahidi A; Siva Sankar DV
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):156-60. PubMed ID: 5524313
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary excretion of catecholamines and their principal metabolites in arterial hypertension].
    Korenev NM; Rasin MS
    Vrach Delo; 1972 Feb; 2():78-81. PubMed ID: 5084752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary study on urinary vanilmandelic acid levels in minimal brain dysfunction].
    Xin RE
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 May; 15(2):116-9. PubMed ID: 7128309
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
    Messiha FS
    J Neurol Sci; 1974 Jan; 21(1):39-46. PubMed ID: 4216622
    [No Abstract]   [Full Text] [Related]  

  • 14. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
    Curtin F; Walker JP; Schulz P
    J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Excretion of vanillic-amygdalic acid and homovanillic acid in patients with bronchial asthma and pneumonia].
    Kolesov DV; Bol'shakova TD; Frolov EP
    Pediatriia; 1968 Dec; 47(12):34-7. PubMed ID: 5717841
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulant drug treatment of hyperactivity: biochemical correlates.
    Elia J; Borcherding BG; Potter WZ; Mefford IN; Rapoport JL; Keysor CS
    Clin Pharmacol Ther; 1990 Jul; 48(1):57-66. PubMed ID: 2196146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion of catecholamine in urine by infants and children with cyanotic congenital heart disease.
    Folger GM; Hollowell JG
    Pediatr Res; 1972 Mar; 6(3):151-7. PubMed ID: 5046972
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary excretion of some monoamines and metabolites in Huntington's chorea.
    McNamee B; Kelvin AS; Turnbull MJ
    Scott Med J; 1971 May; 16(5):247-9. PubMed ID: 4253483
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of reserpine and guanethidine treatment on urinary catecholamines and metabolites in chronic hypertensive dogs.
    Moerman EJ; de Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:310-. PubMed ID: 5052484
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamine metabolism of manic-depressive illness.
    Takahashi R; Nagao Y; Tsuchiya K; Takamizawa M; Kobayashi T; Toru M; Kobayashi K; Kariya T
    J Psychiatr Res; 1968 Dec; 6(3):185-99. PubMed ID: 5731854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.